We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Germany Delays List Of Patented Drugs Targeted For Price Controls

Law360 (April 22, 2004, 12:00 AM EDT) -- A German parliamentary group has postponed the completion of a list of patent-protected drugs for which public health insurers will pay fixed prices.

Nonetheless, fixed prices on patented drugs will be introduced as planned on January 1, 2005, the group said.

GBA, the parliamentary group representing doctors and health insurance funds in the German parliament, had to postpone its decision due to unsettled legislative issues, GBA head Rainer Hess told the Handelsblatt newspaper.

Germany’s public health insurance system is seeking to save 2.5 billion euro in...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.